Skip to main content
Loading...

When regulators come knocking: Ensuring compliance of your promotional material review system

Blog

Electronic records and electronic signatures have become the backbone of modern pharmaceutical operations. Yet, despite decades of implementation, 21 CFR Part 11 compliance remains one of the most challenging aspects of pharmaceutical quality systems. With evolving technology and increasing regulatory scrutiny, understanding and implementing Part 11 requirements has never been more critical.

This comprehensive guide provides pharmaceutical professionals with everything needed to achieve and maintain 21 CFR Part 11 compliance in 2025, from fundamental requirements to practical implementation strategies.

Understanding 21 CFR Part 11: the foundation of electronic records compliance

The Code of Federal Regulations Title 21, Part 11 (21 CFR Part 11) establishes the criteria under which electronic records and electronic signatures are considered trustworthy, reliable, and generally equivalent to paper records and handwritten signatures. Originally published in 1997 and refined through subsequent guidance documents, Part 11 applies to all FDA-regulated industries, with pharmaceutical companies being the most significantly impacted.

Why Part 11 compliance matters more than ever

In 2025, the pharmaceutical industry operates in an increasingly digital environment. Cloud-based systems, artificial intelligence, and remote work have accelerated the adoption of electronic systems. Simultaneously, regulatory agencies worldwide have heightened their focus on data integrity, making Part 11 compliance not just a regulatory requirement, but a competitive necessity.

Non-compliance can result in warning letters, consent decrees, and significant financial penalties. More importantly, it can undermine the integrity of clinical trials, compromise patient safety, and damage organizational reputation.


Subpart B: electronic records
§11.10 Controls for Closed Systems

Closed systems are those where access is controlled by the persons responsible for the content of electronic records. Most pharmaceutical document management systems fall into this category.

System validation and documentation requirements:
  • Validation of systems to ensure accuracy, reliability, consistent intended performance, and the ability to discern invalid or altered records
  • Generation of accurate and complete copies in both human readable and electronic form suitable for inspection, review, and copying by the agency
  • Protection of records to enable their accurate and ready retrieval throughout the records retention period
Access controls:
  • Procedures and controls designed to ensure appropriate access and prevent unauthorized use
  • Use of secure, computer-generated, time-stamped audit trails to independently record the date and time of operator entries and actions
  • Operational system checks to enforce permitted sequencing of steps and events
  • Authority checks to ensure that only authorized individuals can use the system, electronically sign a record, access the operation or computer system input or output device, alter a record, or perform the operation at hand
Data integrity measures:
  • Device checks to determine that proper equipment has been used and the equipment is functioning correctly
  • Determination that persons who develop, maintain, or use electronic record/electronic signature systems have the education, training, and experience to perform their assigned tasks
  • Establishment of, and adherence to, written policies that hold individuals accountable for actions initiated under their electronic signatures
§11.30 Controls for open systems

Open systems are those where access is not controlled by persons responsible for the content of electronic records. These systems require additional controls including document encryption and digital signatures.

Subpart C: electronic signatures
§11.50 Signature manifestations

Electronic signatures must be linked to their respective electronic records to ensure that signatures cannot be excised, copied, or otherwise transferred to falsify other electronic records.

§11.70 Signature/record linking

Electronic signatures and handwritten signatures executed to electronic records must be linked to their respective electronic records to ensure that the signatures cannot be excised, copied, or otherwise transferred to falsify an electronic record at a later time.

§11.100-300 Electronic signature components and controls

Electronic signatures must employ unique identification codes, be under sole control of their purported owner, and require identity verification before each use. The system must create a record of the signing that cannot be altered.

Implementation strategies for 21 CFR Part 11 compliance
1. Risk-based approach to system assessment

Modern Part 11 implementation follows FDA's 2003 guidance emphasizing a risk-based approach. Not all electronic records require the same level of controls. Organizations should:

Conduct a comprehensive risk assessment that evaluates:
  • The impact of record falsification on product quality and patient safety
  • The likelihood of record falsification
  • The detectability of changes to records
  • The consequences of undetected changes
Categorize systems based on risk levels:
  • High risk: Systems containing data directly supporting regulatory submissions, clinical trial data, manufacturing batch records
  • Medium risk: Systems supporting quality operations, supplier management, training records
  • Low risk: Systems with minimal impact on product quality or patient safety

Database design:

Implement proper database normalization and referential integrity constraints. Use timestamp fields that are automatically populated and cannot be modified by users. Ensure that related records maintain logical relationships that prevent orphaned or inconsistent data.

User interface design:

Create interfaces that guide users through proper workflows and prevent unauthorized actions. Implement role-based access controls that limit functionality based on user responsibilities. Design clear audit trails that capture all relevant user actions.

Integration considerations:

When integrating multiple systems, ensure that data integrity is maintained across all interfaces. Implement proper error handling and rollback procedures for failed transactions. Maintain audit trails that span multiple systems when necessary.


Installation qualification (IQ):

Document that the system has been installed according to specifications, including hardware, software, and network components. Verify that all required licenses are in place and that the system meets environmental requirements.

Operational qualification (OQ):

Demonstrate that the system operates according to specifications under all anticipated operating conditions. Test all security features, audit trail functionality, and electronic signature capabilities.

Performance qualification (PQ):

Verify that the system consistently performs according to specifications in the actual operating environment with real users and data loads.


Multi-factor authentication:

Implement robust authentication mechanisms that may include:

  • Something you know (password/PIN)
  • Something you have (token/certificate)
  • Something you are (biometric)
Signature binding:

Ensure that electronic signatures are cryptographically bound to the signed document using technologies such as digital signatures or hash-based linking mechanisms.

Non-repudiation:

Implement controls that prevent signers from later denying that they signed a document. This typically involves secure timestamping and immutable audit trails.


1. Inadequate audit trail implementation

Common mistake: Implementing audit trails that capture insufficient information or that can be modified by users.

Solution: Ensure audit trails capture the "who, what, when, where, and why" of all critical actions. Implement write-once storage for audit records and regularly test the integrity of audit data.

2. Insufficient access controls

Common mistake: Implementing role-based access controls that are too broad or that don't properly segregate duties.

Solution: Follow the principle of least privilege, regularly review user access rights, and implement proper approval workflows for access changes.

3. Poor change control

Common mistake: Making system changes without proper documentation, testing, or approval.

Solution: Implement formal change control procedures that include impact assessment, testing requirements, and approval processes for all system modifications.

4. Inadequate training and awareness

Common mistake: Assuming that users understand Part 11 requirements without proper training.

Solution: Develop comprehensive training programs that cover both system functionality and regulatory requirements. Maintain training records and provide regular refresher training.

5. Backup and recovery shortcomings

Common mistake: Failing to properly test backup and recovery procedures or not maintaining backups for the required retention period.

Solution: Implement robust backup procedures with regular testing of recovery capabilities. Ensure that backed-up data maintains its electronic signature integrity.


Cloud computing and Part 11

Cloud-based systems present unique challenges for Part 11 compliance:

  • Data location and control: Ensure that cloud providers can guarantee data location and provide appropriate controls for data access and modification.
  • Service level agreements: Negotiate SLAs that address Part 11 requirements, including audit trail preservation, backup procedures, and incident response.
  • Vendor assessment: Conduct thorough assessments of cloud providers' security controls, compliance certifications, and change management procedures.
Artificial intelligence and machine learning

AI/ML systems introduce new considerations for Part 11 compliance:

  • Algorithm transparency: Maintain documentation of algorithm logic and decision-making processes to ensure auditability.
  • Training data integrity: Implement controls to ensure the integrity of data used to train AI models.
  • Model versioning: Maintain proper version control for AI models and ensure that the specific version used for each decision is documented.
Mobile and remote access

The increase in remote work requires additional Part 11 considerations:

  • Device security: Implement mobile device management (MDM) solutions that ensure appropriate security controls on devices accessing Part 11 systems.
  • Network security: Use VPN or other secure networking solutions to protect data in transit.
  • User authentication: Implement strong authentication mechanisms that work effectively in remote environments.

21 CFR Part 11 Compliance Checklist

Category Sub-category Checklist Item Done
System Design and Implementation Planning and Assessment Risk assessment completed for all electronic systems
Part 11 applicability determination documented
System design specifications include Part 11 requirements
Vendor assessment completed (if applicable)
Data flow diagrams created and reviewed
Technical Controls User access controls implemented and tested
Audit trail functionality verified and tested
Electronic signature capabilities implemented (if applicable)
Data backup and recovery procedures established
System integration integrity verified
Validation Validation protocol approved and executed
Installation Qualification completed
Operational Qualification completed
Performance Qualification completed
Validation report approved and filed
Procedural Controls Documentation Standard Operating Procedures (SOPs) written and approved
User training materials developed
System administrator procedures documented
Change control procedures established
Incident response procedures defined
Training and Competency User training program implemented
Training records maintained
Competency assessments completed
Refresher training schedule established
Administrator training completed
Ongoing Compliance Monitoring and Maintenance Regular audit trail reviews scheduled and performed
User access reviews conducted quarterly
System performance monitoring implemented
Backup procedures tested regularly
Change control process followed for all modifications
Quality Assurance Internal audit program established
Vendor audits conducted (if applicable)
Corrective action procedures implemented
Management review process established
Continuous improvement program active
Documentation and Records Required Documentation System documentation complete and current
Validation documentation filed and maintained
Training records complete and accessible
Audit trail archives maintained per retention requirements
Change control records maintained
The future of Part 11 compliance

As we move through 2025, several trends are shaping the future of Part 11 compliance:

  • Increased regulatory scrutiny: Regulatory agencies are placing greater emphasis on data integrity and electronic records during inspections. Organizations must be prepared to demonstrate comprehensive compliance.
  • Technology integration: The integration of emerging technologies like blockchain, advanced analytics, and IoT devices will require new approaches to Part 11 compliance.
  • Global harmonization: While Part 11 is an FDA requirement, similar regulations worldwide are creating pressure for harmonized approaches to electronic records compliance.
  • Automated compliance: Advanced compliance monitoring tools and AI-driven audit systems are making it easier to maintain continuous compliance monitoring.
Conclusion: building a sustainable Part 11 compliance program

Achieving 21 CFR Part 11 compliance in 2025 requires a comprehensive approach that combines technical controls, procedural safeguards, and organizational commitment. Success depends on understanding that compliance is not a one-time achievement but an an ongoing process that must evolve with technology and regulatory expectations.

Organizations that invest in robust Part 11 compliance programs benefit from improved data integrity, reduced regulatory risk, and enhanced operational efficiency. The key is to view Part 11 not as a burden, but as a framework for building trustworthy, reliable electronic systems that support quality pharmaceutical operations.

By following the guidance in this comprehensive guide, pharmaceutical professionals can build and maintain Part 11 compliance programs that not only meet current regulatory requirements but are prepared for future challenges and opportunities.

Ready to streamline your Part 11 compliance? ApprovalFlow's pharmaceutical document management platform is designed from the ground up to meet 21 CFR Part 11 requirements. With built-in audit trails, electronic signatures, and comprehensive validation support, ApprovalFlow makes compliance simple and sustainable. Contact our team to learn how we can help your organization achieve bulletproof Part 11 compliance.


Oops. No documents at the moment. Check in later

Download the 21 CFR Part 11 checklist to check if your systems are compliant

Download the PDF now.

Ready to transform your promotional material review process?

Contact us today to learn how ApprovalFlow can help you achieve faster approvals, enhanced compliance, and improved efficiency.